Microfluidic-based systems for the management of diabetes
| dc.contributor.author | Staples, Anne E. | en |
| dc.contributor.author | Zhang, Shuyu | en |
| dc.date.accessioned | 2025-02-24T15:42:35Z | en |
| dc.date.available | 2025-02-24T15:42:35Z | en |
| dc.date.issued | 2024-03-20 | en |
| dc.description.abstract | Diabetes currently affects approximately 500 million people worldwide and is one of the most common causes of mortality in the United States. To diagnose and monitor diabetes, finger-prick blood glucose testing has long been used as the clinical gold standard. For diabetes treatment, insulin is typically delivered subcutaneously through cannula-based syringes, pens, or pumps in almost all type 1 diabetic (T1D) patients and some type 2 diabetic (T2D) patients. These painful, invasive approaches can cause non-adherence to glucose testing and insulin therapy. To address these problems, researchers have developed miniaturized blood glucose testing devices as well as microfluidic platforms for non-invasive glucose testing through other body fluids. In addition, glycated hemoglobin (HbA1c), insulin levels, and cellular biomechanics-related metrics have also been considered for microfluidic-based diabetes diagnosis. For the treatment of diabetes, insulin has been delivered transdermally through microdevices, mostly through microneedle array-based, minimally invasive injections. Researchers have also developed microfluidic platforms for oral, intraperitoneal, and inhalation-based delivery of insulin. For T2D patients, metformin, glucagon-like peptide 1 (GLP-1), and GLP-1 receptor agonists have also been delivered using microfluidic technologies. Thus far, clinical studies have been widely performed on microfluidic-based diabetes monitoring, especially glucose sensing, yet technologies for the delivery of insulin and other drugs to diabetic patients with microfluidics are still mostly in the preclinical stage. This article provides a concise review of the role of microfluidic devices in the diagnosis and monitoring of diabetes, as well as the delivery of pharmaceuticals to treat diabetes using microfluidic technologies in the recent literature. Graphical abstract: (Figure presented.) | en |
| dc.description.version | Published version | en |
| dc.format.extent | Pages 2989-3008 | en |
| dc.format.extent | 20 page(s) | en |
| dc.format.mimetype | application/pdf | en |
| dc.identifier.doi | https://doi.org/10.1007/s13346-024-01569-y | en |
| dc.identifier.eissn | 2190-3948 | en |
| dc.identifier.issn | 2190-3948 | en |
| dc.identifier.issue | 11 | en |
| dc.identifier.orcid | Staples, Anne [0000-0003-4823-8184] | en |
| dc.identifier.other | 10.1007/s13346-024-01569-y (PII) | en |
| dc.identifier.pmid | 38509342 | en |
| dc.identifier.uri | https://hdl.handle.net/10919/124692 | en |
| dc.identifier.volume | 14 | en |
| dc.language.iso | en | en |
| dc.publisher | Springer | en |
| dc.relation.uri | https://www.ncbi.nlm.nih.gov/pubmed/38509342 | en |
| dc.rights | Creative Commons Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
| dc.subject | Microfluidics | en |
| dc.subject | Diabetes | en |
| dc.subject | Insulin | en |
| dc.subject | Drug delivery | en |
| dc.subject | Glucose monitoring | en |
| dc.subject | Glycated hemoglobin | en |
| dc.subject | Metformin | en |
| dc.subject | Microneedle array | en |
| dc.subject.mesh | Animals | en |
| dc.subject.mesh | Humans | en |
| dc.subject.mesh | Diabetes Mellitus | en |
| dc.subject.mesh | Diabetes Mellitus, Type 1 | en |
| dc.subject.mesh | Diabetes Mellitus, Type 2 | en |
| dc.subject.mesh | Insulin | en |
| dc.subject.mesh | Blood Glucose | en |
| dc.subject.mesh | Hypoglycemic Agents | en |
| dc.subject.mesh | Drug Delivery Systems | en |
| dc.subject.mesh | Microfluidic Analytical Techniques | en |
| dc.subject.mesh | Microfluidics | en |
| dc.subject.mesh | Lab-On-A-Chip Devices | en |
| dc.title | Microfluidic-based systems for the management of diabetes | en |
| dc.title.serial | Drug Delivery and Translational Research | en |
| dc.type | Article - Refereed | en |
| dc.type.dcmitype | Text | en |
| dcterms.dateAccepted | 2024-03-04 | en |
| pubs.organisational-group | Virginia Tech | en |
| pubs.organisational-group | Virginia Tech/Engineering | en |
| pubs.organisational-group | Virginia Tech/Engineering/Mechanical Engineering | en |
| pubs.organisational-group | Virginia Tech/All T&R Faculty | en |
| pubs.organisational-group | Virginia Tech/Engineering/COE T&R Faculty | en |